PPXRD-11 PowerPoint and PDF Presentations - Alphabetically by Author
(View in Program)

15 - 18 May 2012, Sanibel Harbour Marriott Resort & Spa, Fort Myers, FL, USA
Exhibition: 16-17 May

 

WELCOMING REMARKS & INTRODUCTIONS FROM THE PROGRAM CHAIR - Dr. Cyrus E. Crowder

-------------------------------------

Using PXRD for Amorphous Materials - Simon Bates

DESOLVATION OF DROPERIDOL ISOSTRUCTURAL SOLVATES - A. Bērziņš

SOLID-FORM SCREENING AND SELECTION: STRATEGIES AND CHALLENGES OF DIFFICULT MOLECULES - P.Y. Chen

ADDRESSING THE AMORPHOUS CONTENT ISSUE IN QUANTITATIVE PHASE ANALYSIS: THE CERTIFICATION OF NIST STANDARD REFERENCE MATERIAL 676A - J. Cline

MATERIAL IDENTIFICATION AND CHARACTERIZATION: 10 YEARS OF DEVELOPMENTS, THE PDF-4/ORGANICS DATABASE - T. G. Fawcett

NEW INSTRUMENTATION FOR PHARMACEUTICAL XRD - B. He

CRYSTAL STRUCTURE PREDICTION: SYNERGY BETWEEN THEORY AND EXPERIMENT - James A. Kaduk

Making Amorphous API - Ann Newman

Using Thermal Techniques for Amorphous Materials - Ann Newman

REGULATORY CONSIDERATIONS ON PHARMACEUTICAL SOLIDS: POLYMORPHS AND CO-CRYSTALS - A. Raw

Ultrafast Lasers for the Detection and Quantification of Trace Crystallinity in Amorphous Formulations by SONICC - Garth Simpson

NUCLEATION AND THE DIFFERING CRYSTALLIZATION BEHAVIOR OF ENANTIOMERS - G. Stephenson

SONICC AND TPE-UVF ANALYSIS OF APIS AND COMMON EXCIPIENTS - S. Toth

MOLECULAR COCRYSTALS AND SALTS: ‘FULL’ STRUCTURAL CHARACTERIZATION FROM POWDER DIFFRACTION DATA - M. Tremayne

AMORPHOUS QUANTITATION STRATEGY FOR CRYSTALLINE DRUG SUBSTANCE – A GSK PERSPECTIVE - P. Varlashkin

The Strategy for Quantitation of Residual Amorphous in Crystalline API - P. Varlashkin

STRUCTURAL CHARACTERIZATION OF SOLID COMPOSITE MATERIALS AS A TOOL FOR DRUG PRODUCT FORMULATION AND DEVELOPMENT - P. Wildfong

THE STUDY OF MICRONIZATION INDUCED DISORDER OF ACTIVE PHARMACEUTICAL INGREDIENTS BY XRPD LINE BROADENING ANALYSES - G. Williams

Amorphous Basics - Lian Yu

AMORPHOUS ORGANIC SOLIDS AND THEIR CRYSTALLIZATION - Lian Yu